Trials / Completed
CompletedNCT00772681
Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma
Phase IV Clinical Study Evaluating The Efficacy of Chemoradiotherapy Following Neoadjuvant Treatment With Docetaxel and Cisplatin in Indifferentiated and Non-keratinized Squamous Cell Carcinoma of Nasopharynx
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 57 (actual)
- Sponsor
- Sanofi · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
* To assess the efficacy of docetaxel, cisplatin combination in terms of disease free survival. * Time to progression of the disease in terms of local and distant failure; assess the survival time, and assess the objective (clinical and radiological) response rate and the safety of the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | docetaxel and cisplatin | 3 cycles of docetaxel 75mg/m2 and 100mg/m2 cisplatin combination every 3 weeks |
Timeline
- Start date
- 2004-10-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2008-10-15
- Last updated
- 2009-12-07
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT00772681. Inclusion in this directory is not an endorsement.